Počet záznamov: 1
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
Názov FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease Autor Novák Petr SCOPUS Kontseková Eva SCOPUS Kováčech Branislav SCOPUS Smolek Tomáš SCOPUS Parrák Vojtech Žilka Norbert SCOPUS Novák Michal SCOPUS Spoluautori Schmidt Reinhold Katina Stanislav Fialova Lubica Prcina Michal Dal-Bianco Peter Brunner Martin Staffen Wolfgang Rainer Michael Ondrus Matej Ropele Stefan Smisek Miroslav Sivak Roman Winblad Bengt Zdroj.dok. Alzheimer's Research & Therapy. Vol. 10 (2018), art. no. 108 Jazyk dok. eng - angličtina Druh dok. rozpis článkov z periodík (rbx) Ohlasy SHABBIR, U. - RUBAB, M. - TYAGI, A. - OH, D.H. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. JAN 2021, vol. 22, no. 1. SOEDA, Y. - TAKASHIMA, A. New Insights Into Drug Discovery Targeting Tau Protein. In FRONTIERS IN MOLECULAR NEUROSCIENCE. ISSN 1662-5099, DEC 3 2020, vol. 13. ZHANG, F. - ZHONG, R.J. - CHENG, C. - LI, S. - LE, W.D. New therapeutics beyond amyloid-beta and tau for the treatment of Alzheimer's disease. In ACTA PHARMACOLOGICA SINICA. ISSN 1671-4083. VAZ, M. - SILVESTRE, S. Alzheimer's disease: Recent treatment strategies. In EUROPEAN JOURNAL OF PHARMACOLOGY. ISSN 0014-2999, NOV 15 2020, vol. 887. SCHEER, V. - GOLDAMMER, M. - FLINDT, S. - VAN ZANDBERGEN, G. - HINZ, T. Therapeutic vaccination for tumors and neurodegenerative diseases. In BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ. ISSN 1436-9990, NOV 2020, vol. 63, no. 11, SI, p. 1373-1379. ORTEGA-TIRADO, D. - ARVIZU-FLORES, A.A. - VELAZQUEZ, C. - GARIBAY-ESCOBAR, A. The role of immunoinformatics in the development of T-cell peptide-based vaccines againstMycobacterium tuberculosis. In EXPERT REVIEW OF VACCINES. ISSN 1476-0584, SEP 1 2020, vol. 19, no. 9, p. 831-841. PLOTKIN, S.S. - CASHMAN, N.R. Passive immunotherapies targeting A beta and tau in Alzheimer's disease. In NEUROBIOLOGY OF DISEASE. ISSN 0969-9961, OCT 2020, vol. 144. CLEMEN, R. - BEKESCHUS, S. Oxidatively Modified Proteins: Cause and Control of Diseases. In APPLIED SCIENCES-BASEL. SEP 2020, vol. 10, no. 18. VANDEVREDE, L. - LJUBENKOV, P.A. - ROJAS, J.C. - WELCH, A.E. - BOXER, A.L. Four-Repeat Tauopathies: Current Management and Future Treatments. In NEUROTHERAPEUTICS. ISSN 1933-7213. VANDEVREDE, L. - BOXER, A.L. - POLYDORO, M. Targeting tau: Clinical trials and novel therapeutic approaches. In NEUROSCIENCE LETTERS. ISSN 0304-3940, JUL 13 2020, vol. 731. ORDONEZ-GUTIERREZ, L. - WANDOSELLU, F. Nanoliposomes as a Therapeutic Tool for Alzheimer's Disease. In FRONTIERS IN SYNAPTIC NEUROSCIENCE. ISSN 1663-3563, MAY 25 2020, vol. 12. GAO, C.H. - CHU, X.Y. - GONG, W. - ZHENG, J.P. - XIE, X.Y. - WANG, Y.L. - YANG, M.Y. - LI, Z.P. - GAO, C.S. - YANG, Y. Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease. In JOURNAL OF NANOBIOTECHNOLOGY. MAY 13 2020, vol. 18, no. 1. SUBRAMANIAN, S. - SAVANUR, G. Antibodies directed to the phospho-tau peptide (residues 111-137) dissociate tau oligomers and reduce the spatial memory deficits in non-transgenic tauopathy model rats. In INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY. ISSN 0019-5189, MAY 2020, vol. 58, no. 5, p. 355-359. ROSLER, T.W. - COSTA, M. - HOGLINGER, G.U. Disease-modifying strategies in primary tauopathies. In NEUROPHARMACOLOGY. ISSN 0028-3908, MAY 1 2020, vol. 167. KWON, S. - IBA, M. - KIM, C. - MASLIAH, E. Immunotherapies for Aging-Related Neurodegenerative Diseases-Emerging Perspectives and New Targets. In NEUROTHERAPEUTICS. ISSN 1933-7213, JUL 2020, vol. 17, no. 3, SI, p. 935-954. MALONIS, R.J. - LAI, J.R. - VERGNOLLE, O. Peptide-Based Vaccines: Current Progress and Future Challenges. In CHEMICAL REVIEWS. ISSN 0009-2665, MAR 25 2020, vol. 120, no. 6, p. 3210-3229. PANZA, F. - LOZUPONE, M. - SERIPA, D. - DANIELE, A. - WATLING, M. - GIANNELLI, G. - IMBIMBO, B.P. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. In NATURE REVIEWS NEUROLOGY. ISSN 1759-4758, APR 2020, vol. 16, no. 4, p. 213-228. CAI, N. - CHEN, J.J. - BI, D.C. - GU, L. - YAO, L.J. - LI, X.T. - LI, H. - XU, H. - HU, Z.L. - LIU, Q. - XU, X. Specific Degradation of Endogenous Tau Protein and Inhibition of Tau Fibrillation by Tanshinone IIA through the Ubiquitin- Proteasome Pathway. In JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. ISSN 0021-8561, FEB 19 2020, vol. 68, no. 7, p. 2054-2062. ZHOU, Q.H. - MARELJIC, N. - MICHAELSEN, M. - PARHIZKAR, S. - HEINDL, S. - NUSCHER, B. - FARNY, D. - CZUPPA, M. - SCHLUDI, C. - GRAF, A. - KREBS, S. - BLUM, H. - FEEDERLE, R. - ROTH, S. - HAASS, C. - ARZBERGER, T. - LIESZ, A. - EDBAUER, D. Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. In EMBO MOLECULAR MEDICINE. ISSN 1757-4676, FEB 7 2020, vol. 12, no. 2. BITTAR, A. - BHATT, N. - KAYED, R. Advances and considerations in AD tau-targeted immunotherapy. In NEUROBIOLOGY OF DISEASE. ISSN 0969-9961, FEB 2020, vol. 134. LEBLHUBER, F. - STEINER, K. - GEISLER, S. - FUCHS, D. - GOSTNER, J.M. On the Possible Relevance of Bottom-up Pathways in the Pathogenesis of Alzheimer's Disease. In CURRENT TOPICS IN MEDICINAL CHEMISTRY. ISSN 1568-0266, 2020, vol. 20, no. 15, p. 1415-1421. ETTCHETO, M. - BUSQUETS, O. - ESPINOSA-JIMENEZ, T. - VERDAGUER, E. - AULADELL, C. - CAMINS, A. A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease. In CURRENT PHARMACEUTICAL DESIGN. ISSN 1381-6128, 2020, vol. 26, no. 12, p. 1286-1299. DERRY, P.J. - HEGDE, M.L. - JACKSON, G.R. - KAYED, R. - TOUR, J.M. - TSAI, A.L. - KENT, T.A. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective. In PROGRESS IN NEUROBIOLOGY. ISSN 0301-0082, JAN 2020, vol. 184. BALL, K. - SULLIVAN, K.A. - RYAN, M. - BETHISHOU, L. - LEWIS, J. Pharmacists a valuable resource for patients with Alzheimer disease and their caregivers. In JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION. ISSN 1544-3191, NOV-DEC 2019, vol. 59, no. 6, p. 769-775. MCALARY, L. - PLOTKIN, S.S. - CASHMAN, N.R. Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases. In CNS DRUGS. ISSN 1172-7047, SEP 2019, vol. 33, no. 9, p. 883-904. LOERA-VALENCIA, R. - CEDAZO-MINGUEZ, A. - KENIGSBERG, P.A. - PAGE, G. - DUARTE, A.I. - GIUSTI, P. - ZUSSO, M. - ROBERT, P. - FRISONI, G.B. - CATTANEO, A. - ZILLE, M. - BOLTZE, J. - CARTIER, N. - BUEE, L. - JOHANSSON, G. - WINBLAD, B. Current and emerging avenues for Alzheimer's disease drug targets. In JOURNAL OF INTERNAL MEDICINE. ISSN 0954-6820, OCT 2019, vol. 286, no. 4, p. 398-437. LIU, P.P. - XIE, Y. - MENG, X.Y. - KANG, J.S. History and progress of hypotheses and clinical trials for Alzheimer's disease. In SIGNAL TRANSDUCTION AND TARGETED THERAPY. ISSN 2095-9907, AUG 23 2019, vol. 4. YANG, H.Y. - CHENG, Z.H. - LI, Z.M. - JIANG, Y. - ZHAO, J.F. - WU, Y. - GU, S.Q. - XU, H. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities. In INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. ISSN 0885-6230, NOV 2019, vol. 34, no. 11, p. 1658-1666. TAPIA-ROJAS, C. - CABEZAS-OPAZO, F. - DEATON, C.A. - VERGARA, E.H. - JOHNSON, G.V.W. - QUINTANILLA, R.A. It's all about tau. In PROGRESS IN NEUROBIOLOGY. ISSN 0301-0082, APR 2019, vol. 175, p. 54-76. MARTINELLI, A.H.S. - LOPES, F.C. - JOHN, E.B.O. - CARLINI, C.R. - LIGABUE-BRAUN, R. Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1422-0067, MAR 15 2019, vol. 20, no. 6. DONG, Y. - LI, X.H. - CHENG, J.B. - HOU, L. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1422-0067, FEB 1 2019, vol. 20, no. 3. IQBAL, K. - LIU, F. - GONG, C.X. - DAI, C.L. - HU, W. Why delay in effective treatment for Alzheimer's disease and related conditions. In MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A. ISSN 1877-1173, 2019, vol. 168, p. 243-256. LOGROSCINO, G. - IMBIMBO, B.P. - LOZUPONE, M. - SARDONE, R. - CAPOZZO, R. - BATTISTA, P. - ZECCA, C. - DIBELLO, V. - GIANNELLI, G. - BELLOMO, A. - GRECO, A. - DANIELE, A. - SERIPA, D. - PANZA, F. Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs. In EXPERT OPINION ON PHARMACOTHERAPY. ISSN 1465-6566, 2019, vol. 20, no. 9, p. 1091-1107. WINKLER, D. - LEYHE, T. Alzheimer's disease - State of the art, and emerging diagnostics and therapeutics. In THERAPEUTISCHE UMSCHAU. ISSN 0040-5930, JUL 2018, vol. 75, no. 7, p. 432-437. CONGDON, E.E. - JIANG, Y.X. - SIGURDSSON, E.M. Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly. In SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. ISSN 1084-9521, JUN 2022, vol. 126, SI, p. 125-137. HAMID, F.A. - MARKER, C.L. - RALEIGH, M.D. - KHAIMRAJ, A. - WINSTON, S. - PENTEL, P.R. - PRAVETONI, M. Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. In VACCINE. ISSN 0264-410X, MAY 20 2022, vol. 40, no. 23, p. 3244-3252. ARGUETA, N. - NOTARI, E. - SZIGETI, K. Role of Pharmacogenomics in Individualizing Treatment for Alzheimer's Disease. In CNS DRUGS. ISSN 1172-7047, APR 2022, vol. 36, no. 4, p. 365-376. SONG, C.H. - SHI, J.Y. - ZHANG, P.A. - ZHANG, Y.F. - XU, J.R. - ZHAO, L.X. - ZHANG, R. - WANG, H. - CHEN, H.Z.A. Immunotherapy for Alzheimer's disease: targeting beta-amyloid and beyond. In TRANSLATIONAL NEURODEGENERATION. ISSN 2047-9158, MAR 18 2022, vol. 11, no. 1. BOEVE, B.F. - BOXER, A.L. - KUMFOR, F. - PIJNENBURG, Y. - ROHRER, J.D. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. In LANCET NEUROLOGY. ISSN 1474-4422, MAR 2022, vol. 21, no. 3, p. 258-272. TASHIMA, T. Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis. In PHARMACEUTICS. FEB 2022, vol. 14, no. 2. KIPER, K. - FREEMAN, J.L. Use of Zebrafish Genetic Models to Study Etiology of the Amyloid-Beta and Neurofibrillary Tangle Pathways in Alzheimer's Disease. In CURRENT NEUROPHARMACOLOGY. ISSN 1570-159X, 2022, vol. 20, no. 3, p. 524-539. VASSILAKOPOULOU, V. - KARACHALIOU, C.E. - EVANGELOU, A. - ZIKOS, C. - LIVANIOU, E. Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives. In VACCINES. NOV 2021, vol. 9, no. 11. IMBIMBO, B.P. - IPPATI, S. - WATLING, M. - BALDUCCI, C. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies. In ALZHEIMERS & DEMENTIA. ISSN 1552-5260, MAY 2022, vol. 18, no. 5, p. 1008-1037. YU, T.W. - LANE, H.Y. - LIN, C.E.H. Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. AUG 2021, vol. 22, no. 15. WU, K.M. - ZHANG, Y.R. - HUANG, Y.Y. - DONG, Q. - TAN, L. - YU, J.T. The role of the immune system in Alzheimer's disease. In AGEING RESEARCH REVIEWS. ISSN 1568-1637, SEP 2021, vol. 70. JI, C.Y. - SIGURDSSON, E.M. Current Status of Clinical Trials on Tau Immunotherapies. In DRUGS. ISSN 0012-6667, JUL 2021, vol. 81, no. 10, p. 1135-1152. MORTADA, I. - FARAH, R. - NABHA, S. - OJCIUS, D.M. - FARES, Y. - ALMAWI, W.Y. - SADIER, N.S. Immunotherapies for Neurodegenerative Diseases. In FRONTIERS IN NEUROLOGY. ISSN 1664-2295, JUN 7 2021, vol. 12. NAKAI, T. - YAMADA, K. - MIZOGUCHI, H. Alzheimer's Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. JUN 2021, vol. 22, no. 11. BOUTAJANGOUT, A. - ZHANG, W. - KIM, J. - ABDALI, W.A. - PRELLI, F. - WISNIEWSKI, T. Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer's Mouse Model With Tau Pathology. In FRONTIERS IN AGING NEUROSCIENCE. ISSN 1663-4365, FEB 25 2021, vol. 13. JI, W.B. - GONG, B.F. - JIN, H. - CHEN, X.H. - LI, P. - CHENG, W.B. - ZHAO, Y.C. - HE, B. - ZHUANG, J.H. - GAO, J. - YIN, Y. Recent Progress Towards Vaccines and Antibody-based Therapies Against Alzheimer's Disease. In MINI-REVIEWS IN MEDICINAL CHEMISTRY. ISSN 1389-5575, 2021, vol. 21, no. 19, p. 3062-3072. LJUBENKOV, P.A. - BOXER, A.L. FTLD Treatment: Current Practice and Future Possibilities. In FRONTOTEMPORAL DEMENTIAS: EMERGING MILESTONES OF THE 21ST CENTURY. ISSN 0065-2598, 2021, vol. 1281, p. 297-310. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2018 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.1186/s13195-018-0436-1 
článok
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2018 2017 5.015 Q1 2.449 Q1
Počet záznamov: 1